InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-42.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Lui Alfred Fu Kong, 董事. Director active across 1 company, notably Emmaus Life Sciences, Inc.. Cumulatively, 1 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 3 January 2022. The latest transaction was disclosed on 3 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lui Alfred Fu Kong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
10,000 股@ US$1.58100.0% 占其流量Common stock, $0.001 par valueSEC:0001209191-22-001710:0
标准退出：2022年4月3日 (T+90)
1 条申报中的 1 条
About Lui Alfred Fu Kong
Alfred Fu Kong Lui serves as a Director at Emmaus Life Sciences, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the life sciences sector is a valuable asset for the board. He is committed to supporting Emmaus in its growth and innovation initiatives.
